Detalhe da pesquisa
1.
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.
Eur J Cancer
; 205: 114101, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735161
2.
VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types-A Meta-Analysis.
Cancers (Basel)
; 15(20)2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894379
3.
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
Clin Cancer Res
; 29(13): 2513-2524, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790412
4.
The effect of organ-specific tumor microenvironments on response patterns to immunotherapy.
Front Immunol
; 13: 1030147, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466910
5.
Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma.
Front Mol Biosci
; 9: 810858, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664673
6.
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688560
7.
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096531
8.
Comprehensive analysis of cutaneous and uveal melanoma liver metastases.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262254
9.
Feasibility of Crosslinked Acrylic Shape Memory Polymer for a Thrombectomy Device.
Smart Mater Struct
; 2014: 971087, 2014 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414549